Literature DB >> 27500111

Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis.

Mehdi Zandian1, Neda Rahimian2, Sanaz Soheilifar3.   

Abstract

AIM: To compare the effect of azithromycin drop and doxycycline capsule on treatment of posterior blepharitis.
METHODS: Fifty patients (100 eyes) with moderate posterior blepharitis, randomly divided into two therapeutic groups; all the patients got warm eyelid compress and massage three times a day for 3wk. In addition the first group got azithromycin 1% drop, twice daily for 1wk and then one drop daily for 2wk. The second group got oral doxycycline 100 mg daily for 3wk. At the end of the research, patients' signs and symptoms were compared together. ANOVA, Chi-square and Mann-Whitney tests were used for statistical analysis.
RESULTS: Topical therapy with azithromycin and oral therapy with doxycycline relieved signs and symptoms after 3wk. There were no significant differences between symptoms healing rate and foreign body sensation healing in these two groups (P>0.05). However, azithromycin drop was more effective in reduction of eye redness and doxycycline was more effective in meibomian glands plugging healing and reducing the corneal staining.
CONCLUSION: Topical azithromycin could have similar effects as oral doxycycline on posterior blepharitis in improving subjective symptoms. However, doxycycline can reduce objective signs such as ocular surface staining and meibomian gland plugging more than azithromycin.

Entities:  

Keywords:  azithromycin; blepharitis; doxycycline

Year:  2016        PMID: 27500111      PMCID: PMC4951657          DOI: 10.18240/ijo.2016.07.14

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  25 in total

1.  Comparison between normal values of 2- and 5-minute Schirmer test without anesthesia.

Authors:  Vasileios Karampatakis; Athanasios Karamitsos; Athanasia Skriapa; Georgios Pastiadis
Journal:  Cornea       Date:  2010-05       Impact factor: 2.651

2.  Treatment of ocular rosacea with once-daily low-dose doxycycline.

Authors:  Bianka Sobolewska; Deshka Doycheva; Christoph Deuter; Ines Pfeffer; Martin Schaller; Manfred Zierhut
Journal:  Cornea       Date:  2014-03       Impact factor: 2.651

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.

Authors:  Kari B Green-Church; Igor Butovich; Mark Willcox; Douglas Borchman; Friedrich Paulsen; Stefano Barabino; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

4.  Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial.

Authors:  Mohsen Bahmani Kashkouli; Ali Jalili Fazel; Victoria Kiavash; Marzieh Nojomi; Leila Ghiasian
Journal:  Br J Ophthalmol       Date:  2014-08-19       Impact factor: 4.638

5.  Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.

Authors:  William C Stewart; Christopher S Crean; Richard C Zink; Kurt Brubaker; Reza M Haque; David G Hwang
Journal:  Am J Ophthalmol       Date:  2010-09-01       Impact factor: 5.258

6.  In Vitro Anti-inflammatory and Immunomodulatory Effects of Ciprofloxacin or Azithromycin in Staphylococcus aureus-Stimulated Murine Macrophages are Beneficial in the Presence of Cytochalasin D.

Authors:  Somrita Dey; Arnab Majhi; Sayantika Mahanti; Ipsita Dey; Biswadev Bishayi
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

7.  Oral azithromycin for treatment of posterior blepharitis.

Authors:  Thais Zamudio Igami; Ricardo Holzchuh; Tammy Hentona Osaki; Ruth Miyuki Santo; Newton Kara-Jose; Richard Y Hida
Journal:  Cornea       Date:  2011-10       Impact factor: 2.651

8.  Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation?

Authors:  Yang Liu; Wendy R Kam; Juan Ding; David A Sullivan
Journal:  Cornea       Date:  2015-03       Impact factor: 2.651

9.  Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.

Authors:  Thomas John; Ami A Shah
Journal:  Ann Ophthalmol (Skokie)       Date:  2008

10.  Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms.

Authors:  Longhui Han; Wenru Su; Jingwen Huang; Jingwen Zhou; Sujuan Qiu; Dan Liang
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

View more
  6 in total

1.  [Corneal alterations in eyelid diseases].

Authors:  Elisabeth M Messmer
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

2.  Oral antibiotics for chronic blepharitis.

Authors:  Neil Onghanseng; Sueko M Ng; Muhammad Sohail Halim; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

Review 3.  Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin.

Authors:  Tianchang Tao; Liming Tao
Journal:  Eye (Lond)       Date:  2020-04-28       Impact factor: 3.775

4.  Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction.

Authors:  Kerry B Hagen; Raman Bedi; Caroline A Blackie; Kellie J Christenson-Akagi
Journal:  Clin Ophthalmol       Date:  2018-01-17

Review 5.  An eye for azithromycin: review of the literature.

Authors:  Kostas A Kagkelaris; Olga E Makri; Constantine D Georgakopoulos; George D Panayiotakopoulos
Journal:  Ther Adv Ophthalmol       Date:  2018-07-30

6.  Efficacy of Azithromycin Eyedrops for Individuals With Meibomian Gland Dysfunction-Associated Posterior Blepharitis.

Authors:  Reiko Arita; Shima Fukuoka
Journal:  Eye Contact Lens       Date:  2021-01-01       Impact factor: 3.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.